BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1366 related articles for article (PubMed ID: 15378187)

  • 1. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy.
    Fiorino C; Foppiano F; Franzone P; Broggi S; Castellone P; Marcenaro M; Calandrino R; Sanguineti G
    Radiother Oncol; 2005 Feb; 74(2):187-95. PubMed ID: 15734207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
    Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
    Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?
    Livsey JE; Wylie JP; Swindell R; Khoo VS; Cowan RA; Logue JP
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1076-81. PubMed ID: 15519777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R; Cooper S; Chen Z; Schuster DM
    J Nucl Med; 2017 Mar; 58(3):412-418. PubMed ID: 27609792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
    Sefrova J; Odrazka K; Paluska P; Belobradek Z; Brodak M; Dolezel M; Prosvic P; Macingova Z; Vosmik M; Hoffmann P; Louda M; Nejedla A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):911-8. PubMed ID: 21420244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer.
    De Meerleer GO; Villeirs GM; Vakaet L; Delrue LJ; De Neve WJ
    Strahlenther Onkol; 2004 Sep; 180(9):573-81. PubMed ID: 15378188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
    Liu F; Ahunbay E; Lawton C; Li XA
    Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
    Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
    Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy.
    Jani AB; Spelbring D; Hamilton R; Blend MJ; Pelizzari C; Brendler C; Krauz L; Vijayakumar S; Sapra B; Weichselbaum RR
    J Nucl Med; 2004 Feb; 45(2):238-46. PubMed ID: 14960642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
    Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy.
    Gawish A; Chughtai AA; Eble MJ
    Strahlenther Onkol; 2019 May; 195(5):383-392. PubMed ID: 30334066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.